Furosemide Stress Test Predicting Early Graft Function in Kidney Transplantation
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-80
SponsorKing Chulalongkorn Memorial Hospital
Furosemide is an old drug that has been used frequently in the postoperative period of kidney transplantation, aiming to achieve adequate urine output. There is no previous study that directly evaluate the urine response to standardized dose of furosemide in the postoperative period. The objective is to measure the urine output after standardized dose of furosemide is delivered, as a biomarker to predict the graft function in perioperative period.
Deceased donor kidney transplantation at KCMH
informed consent is accepted
Known allergy to furosemide
Surgical complication of allograft
Urgently needed for dialysis (refractory hypervolemia, uremic symptoms, and hyperkalemia)